IRIDEX Corp. (IRIX)
0.6432
+0.01
(+1.77%)
USD |
NASDAQ |
Oct 02, 16:00
0.6404
0.00 (0.00%)
After-Hours: 20:00
IRIDEX Net Income (Quarterly) : -1.266M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.266M |
| March 31, 2026 | -0.524M |
| December 31, 2025 | -0.184M |
| September 30, 2025 | -1.573M |
| June 30, 2025 | -0.994M |
| March 31, 2025 | -1.686M |
| December 31, 2024 | -0.834M |
| September 30, 2024 | -1.933M |
| June 30, 2024 | -2.679M |
| March 31, 2024 | -3.464M |
| December 31, 2023 | -2.96M |
| September 30, 2023 | -1.754M |
| June 30, 2023 | -2.766M |
| March 31, 2023 | -2.09M |
| December 31, 2022 | -1.148M |
| September 30, 2022 | -1.767M |
| June 30, 2022 | -2.241M |
| March 31, 2022 | -2.391M |
| December 31, 2021 | -2.443M |
| September 30, 2021 | -2.165M |
| June 30, 2021 | 1.393M |
| March 31, 2021 | -2.01M |
| December 31, 2020 | -0.179M |
| September 30, 2020 | -1.719M |
| June 30, 2020 | -2.78M |
| Date | Value |
|---|---|
| March 31, 2020 | -1.651M |
| December 31, 2019 | -1.561M |
| September 30, 2019 | -1.785M |
| June 30, 2019 | -2.419M |
| March 31, 2019 | -3.048M |
| December 31, 2018 | -2.856M |
| September 30, 2018 | -3.074M |
| June 30, 2018 | -3.28M |
| March 31, 2018 | -3.603M |
| December 31, 2017 | -5.155M |
| September 30, 2017 | -3.096M |
| June 30, 2017 | -2.75M |
| March 31, 2017 | -1.866M |
| December 31, 2016 | -10.82M |
| September 30, 2016 | -0.671M |
| June 30, 2016 | -0.328M |
| March 31, 2016 | 0.101M |
| December 31, 2015 | 0.438M |
| September 30, 2015 | 0.442M |
| June 30, 2015 | -0.652M |
| March 31, 2015 | 0.246M |
| December 31, 2014 | 8.764M |
| September 30, 2014 | 0.49M |
| June 30, 2014 | 0.297M |
| March 31, 2014 | 0.487M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| IDEXX Laboratories, Inc. | 338.41M |
| Neogen Corp. | -11.30M |
| QuidelOrtho Corp. | -92.90M |
| Aspira Women's Health, Inc. | -2.42M |
| Biomerica, Inc. | -1.145M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 12.57M |
| Total Expenses (Quarterly) | 13.83M |
| EPS Diluted (Quarterly) | -0.0727 |
| Enterprise Value | 16.56M |
| Gross Profit Margin (Quarterly) | 33.56% |
| Profit Margin (Quarterly) | -10.07% |
| Earnings Yield | -32.06% |
| Normalized Earnings Yield | -32.04 |